AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by AC Immune SA for the month of March 2018. The filing was submitted on March 20, 2018, and signed by CEO Andrea Pfeifer and CFO Joerg Hornstein. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a cover sheet referencing exhibits rather than a standalone financial statement.
Material Changes
The filing text does not provide data to compare current performance against prior periods. Material changes are likely detailed in the referenced exhibits, specifically the 2017 Statutory Annual Report.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, or specific risk factors. The document lists three exhibits: a Press Release dated March 20, 2018, the 2017 Statutory Annual Report, and the 2017 Compensation Report.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Press Release) for immediate operational updates.
- Review Exhibit 99.2 (2017 Statutory Annual Report) for audited financial results and historical performance.
- Confirm the company's status as a Form 20-F filer for future reporting expectations.